A South American company just pumped the first crude out of the Western hemisphere's largest oil discovery in 30 years. Reserves are worth an estimated $560 billion at today's prices! And shares are likely to take off. To get the full details on this stock, and two other explosive companies, go here.
GE, More Mutual Fund than Company
General Electric (NYSE: GE) reported a 47% decline in their fourth quarter earnings almost a week ago. But we’re still trying to get a handle on just what GE does.
Looking at their website, we’ve discovered they have no less than 14 divisions. Aviation, Electrical Distribution, Business financing, Healthcare, Media & Entertainment, Rail, Water, Appliances, Consumer Electronics, Energy, Consumer Financing, Lighting, Oil & Gas, and Security.
It sounds more like a phone book directory than a company’s business segments. Consider that GE’s revenue is almost 30 billion more than the gross domestic product of Kuwait. No matter how you cut it, that’s a massive organization.
But in the grand scheme of things, the number of business segments doesn’t matter as long as GE can remain profitable. The problem is that even if one or two divisions have a great quarter, if the other 12 don’t, then GE runs a loss. A company this size profits on a macro-scale along with national economies.
At issue for investors is whether GE’s CEO, Jeffrey Immelt, can afford to leave the dividend unchanged.
And that may be a lose-lose situation for Immelt. If they cut, they lose face with shareholders. If they don’t cut, they risk eating into their cash reserves and threatening their AAA credit rating. Neither situation is ideal, but the longer the recession goes, the more likely it is that one of these outcomes will happen.
Companies mentioned in this article: GE.
- FLIR Systems, Inc. (Nasdaq: FLIR): Stock of the Day
- Income Investors: Dump GE & Buy This Safer Income Investment Instead
- GE Looking Better and Better
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed